COMPANY

Helio Genomics

HQ: Irvine, CA source · heliogenomics.com ↗ · West Coast

Keywords: oncology Liver Cirrhosis Chronic Hepatitis Hepatitis B Hepatitis C Diabetes COPD Liver Cancer HCC Hepatocellular Carcinoma Hepatocellular Carcinoma by AJCC Stage

Location: Irvine, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

5Trials (company is sponsor)

Timeline

Mar 1, 2022 Trial start —: Multi-analyte Blood Test Clinical Trial source ↗
Sep 1, 2021 Trial start —: HELIO Liver Test Performance Study in China (HEPATIC) source ↗
Apr 20, 2020 Trial start —: Performance Evaluation (Sensitivity/Specificity) of HelioLiver Test for Detection of HCC source ↗
May 21, 2019 Trial start —: Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer source ↗
Feb 4, 2019 Trial start —: Clinical Trial Multi-analyte Blood Test source ↗

Upcoming milestones

2027-12 (ESTIMATED) · · Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer · NCT05181826
2027-12 (ESTIMATED) · · Multi-analyte Blood Test Clinical Trial · NCT05199259

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 5

Record	Title	Phase	Status	Start	Primary completion
NCT03694600	Clinical Trial Multi-analyte Blood Test	Not listed	Active, not recruiting	Feb 4, 2019	Feb 1, 2023 (actual)
NCT05181826	Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer	Not listed	Recruiting	May 21, 2019	2027-12 (estimated)
NCT05199259	Multi-analyte Blood Test Clinical Trial	Not listed	Recruiting	Mar 1, 2022	2027-12 (estimated)
NCT05053412	HELIO Liver Test Performance Study in China (HEPATIC)	Not listed	Completed	Sep 1, 2021	Mar 1, 2024 (actual)
NCT05059665	Performance Evaluation (Sensitivity/Specificity) of HelioLiver Test for Detection of HCC	Not listed	Completed	Apr 20, 2020	Jul 1, 2021 (actual)